Reviewer's report
Title:Medication adherence and persistence in the treatment of Canadian
ulcerative colitis patients: analyses with the RAMQ database
Version: 2Date:11 October 2012
Reviewer: yvette leung
Reviewer's report:
Minor essential revisions:
Did you exclude 5-ASA prescriptions for microscopic colitis?
How did you account for cesssation of therapy because the patient was given a
new presciption for another drug if 5-ASA was ineffective? Eg. initiation of imuran
or remicade
How do the results of your study add to the literature?
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
I declare that I have no competing interests
Reviewer's report
Title:Medication adherence and persistence in the treatment of Canadian
ulcerative colitis patients: analyses with the RAMQ database
Version: 2Date:11 October 2012
Reviewer: yvette leung
Reviewer's report:
Minor essential revisions:
Did you exclude 5-ASA prescriptions for microscopic colitis?
How did you account for cesssation of therapy because the patient was given a
new presciption for another drug if 5-ASA was ineffective? Eg. initiation of imuran
or remicade
How do the results of your study add to the literature?
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
I declare that I have no competing interests
Please review this paper.
user
Reviewer's report
Title:Medication adherence and persistence in the treatment of Canadian
ulcerative colitis patients: analyses with the RAMQ database
Version: 2Date:11 October 2012
Reviewer: yvette leung
Reviewer's report:
Minor essential revisions:
Did you exclude 5-ASA prescriptions for microscopic colitis?
How did you account for cesssation of therapy because the patient was given a
new presciption for another drug if 5-ASA was ineffective? Eg. initiation of imuran
or remicade
How do the results of your study add to the literature?
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
I declare that I have no competing interests
assistant